Effects of Self-administration of Medication During Hospitalization on Medication Safety, Adherence, and Patient Satisfaction in Dutch Hospitals
- Conditions
- Patient SafetyMedication SafetyPatient Empowerment
- Interventions
- Behavioral: Self-administration of medication (SAM)
- Registration Number
- NCT03728855
- Lead Sponsor
- Radboud University Medical Center
- Brief Summary
During hospitalization, medication administration errors (MAEs) occur daily in health care and can lead to serious harm. Improvement of medication safety is a major concern to policymakers and health care workers. Inpatient self-administration of medication (SAM) during hospital admission could be a way to reduce MAEs. Therefore the aim of this study is to determine the effect of inpatient self-administration of medication on the number of medication administration errors during hospitalization.
- Detailed Description
Objective: the main objective of this study is to determine the effect of inpatient self-administration of medication on the number of medication administration errors during hospitalization. The secondary objectives of this study are to determine:
1. The effect of inpatient self-administration of medication on the severity of medication administration errors during hospitalization
2. The effect of inpatient self-administration on medication adherence after hospitalization
3. The effect of inpatient self-administration of medication on patient satisfaction during hospitalization
4. The effect of inpatient self-administration of medication on staff satisfaction during hospitalization
Study design: multicentre prospective quasi-experimental study with a pre-post design
Study population: hospitalized ≥ 16 years old patients
Intervention: the implementation of self-administration of medication by hospitalized patients. SAM will be compared to standard care.
Main study parameters: The primary outcome measure of the study is the proportion of medication administrations with one or more medication administration errors (MAEs). Secondary outcome measures will be: severity of MAEs, medication adherence after hospitalization, patient satisfaction during hospitalization, and staff satisfaction. For all outcome measures the effect of SAM will be compared to standard care.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: all subjects have to fulfil two questionnaires, one during hospitalization and one approximately three months after leaving the studied ward, e.g. hospital discharge or transfer. The subjects that are included in de post study period have to self-administrate medication that's suitable for SAM. The risk of SAM during hospitalization is estimated as the risk patients are at home when using medication. The burden of SAM is classified as low because results of a recent questionnaire shows that admitted patients have the urge to act in SAM schemes.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 193
- All patients (≥ 16 years old) admitted to the ward who use medication or will be using medication at home after hospital discharge and are able to administer (part of) this medication themselves
- Not providing informed consent
- The use of a medication box without original medication boxes
- The use of medication pre-packaged by automated dispensing system
- The need of homecare support to administer medication
- The need of an informal caretaker to help with medication administration
- Admitted from a nursing home and medication is under supervision of the staff
- Not understanding the Dutch language, written or spoken
- The subject is not capable of managing SAM (due to mental or physical state)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description Self-administration of medication (SAM) Self-administration of medication (SAM) During SAM medication is stocked at the patient's bedside. When medication is scheduled to be administered, patients collect those form their own stock, administer, and document the administration by themselves. Once daily nurses check whether patients succeeded in administration for all prescriptions of the last 24 hours. Each day, patients are qualified for SAM. In the case patients do not meet the criteria of SAM, they will be excluded from SAM.
- Primary Outcome Measures
Name Time Method Proportion of medication administration errors 2 weeks The doctor's prescriptions as noted in the CPOE system will be compared to the observed medication administration and any discrepancy will be marked as an MAE. The number of erroneous medication administrations (containing 1 or more errors) will be divided by the number of observed drug administrations plus the number of omissions (concept of opportunities).
- Secondary Outcome Measures
Name Time Method Severity of MAEs 2 weeks Severity of MAEs will be determined by two healthcare professionals, a physician and a pharmacist.To classify the severity of MAEs the NCC MERP Index for categorizing medication errors will be used. Thereafter consensus will be reached. The experts will be blinded to the period (usual care or intervention) during which the problem occurred.
Medication adherence after hospitalization 1 year With the use of the pharmacy refill dates the Medication Refill Adherence (MRA) is calculated.
- 1 year after inclusion: pharmacy refill data will be collectedPatient satisfaction during hospitalization 7 days Patient satisfaction will be measured by the Beliefs about Medicine Questionnaire (BMQ).
Staff satisfaction 1 year Staff satisfaction will be measured using The Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM). These are four-item measures of implementation outcomes that are often considered "leading indicators" of implementation success. These measures can be administered to a wide range of stakeholders to determine the extent to which they believe an intervention or an implementation strategy is acceptable, appropriate, and feasible. At the end of the study hospital staff will be asked to complete the questionnaires.
Trial Locations
- Locations (8)
Sint Maartenskliniek
🇳🇱Ubbergen, Gelderland, Netherlands
Radboudumc
🇳🇱Nijmegen, Gelderland, Netherlands
Catharina Ziekenhuis
🇳🇱Eindhoven, Noord-Brabant, Netherlands
Groene Hart Ziekenhuis
🇳🇱Gouda, Zuid-Holland, Netherlands
ETZ
🇳🇱Tilburg, Noord-Brabant, Netherlands
MUMC+
🇳🇱Maastricht, Limburg, Netherlands
Meander Medisch Centrum
🇳🇱Amersfoort, Netherlands
Jeroen Bosch Ziekenhuis
🇳🇱's-Hertogenbosch, Noord-Brabant, Netherlands